SYK Stryker Corporation
Trend channel, buy level and 3-month target. Information only, not financial advice.
Inside the channel · 18-month channel falling
Price is between the lines.
- 18-month channel
- US$262.20 – US$342.67 · falling, −17% a year
- Price in channel
- 36% (0% = floor, 100% = ceiling)
- Ceiling overhead
- US$342.67
- Turns bearish below
- US$262.20
What broke this trend
- The fall
- -33% from US$399.4825 July 2025 → 24 Sept 2026
- Whose problem it was
- This company1 of 3 Medical - Devices peers fell with it
- Does it resolve?
- Temporary falls like it have resolved on the record
- Regained so far
- 17%of what it lost
- What the record says
- 85% of 1279 comparable falls came back, typically in 70 days measured across every stock we hold history for, its peer group being too small
Fell -33% (25 July 2025 → 24 Sept 2026); regained 17% so far; company-specific.
Reported at the time: A Look Into Stryker Inc's Price Over Earnings — 25 July 2025
Price history, with the path projected 3 months forward
Updated 10:51 PM ET (37 h ago)
- Daily close
- Upper trend line (18 months)
- Lower trend line (18 months)
- Dashed after today: projected 3 months
- Our buy
- Our target
Suggested path
Buy at or below
US$283.09
level as at 20 Nov 2026
Our target
US$305.74
by 28 Nov 2026
Projected move
8.0%
gross, before costs
Price is between our buy and target.
Target: SYK's usual move size (8.0%), the best return per day on this path.
This move size: reached in 44% of 9 past stretches, typically in 43 days. (0.19% per day)
- Upper line touches
- 7
- Lower line touches
- 4
- Fit confidence
- 43%
- Fitted
- 1 Nov 2026
Company information
About Stryker Corporation
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Kevin A. Lobo
- Employees
- 56,000
- Country
- US
Scorecard
Our own scores from the fundamentals below (not Morningstar ratings).
- Valuation
- —
- Profitability
- —
- Financial health
- —
- Cash generation
- —
Key statistics
- Market cap
- US$116.61B
- Enterprise value
- —
- Beta
- 0.78
- Avg volume
- 2.63M
- Revenue per share
- —
- Dividend yield
- —
- 52-week range
- 267-389.33
- Exchange
- NYSE
Key ratios
- P/E (TTM)
- —
- PEG
- —
- Price / sales
- —
- Price / book
- —
- EV / EBITDA
- —
- Gross margin
- —
- Operating margin
- —
- Net margin
- —
- Current ratio
- —
- Quick ratio
- —
- Debt / equity
- —
- Interest cover
- —
Income statement
Balance sheet
Cash flow
Trend lines are fitted to past swing highs and lows and may not continue. Information only, not financial advice.